LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -
Aplikace | 2017 | ShimadzuInstrumentace
LC/MS, LC/MS/MS, LC/QQQ
ZaměřeníKlinická analýza
VýrobceShimadzu
Klíčová slovamultiplex, antibody, structure, confirmation, nsmol, brentuximab, quantitation, cetuximab, rituximab, drugs, mrm, nsmoltm, vedotin, analysis, plasma, proteolysis, human, chromatograms, news, accuracy, shimadzu, asgytftsy, sgipar, vliyaasnle, average, antibodies, nmhwvk, sqvffk, precision, set, peptides, single, peptide, selective, variety, chief, kit, selection, fulfilled, concentration, drug, paradigm, fab, issued, many, data, guideline, reflect, gas, multiple
Podobná PDF
LCMS Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 4 - Multiplex Analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E119A Application News No. C148A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using FabSelective Proteolysis nSMOL - Part 4 - Multiplex Analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Klíčová slova
multiplex, multiplexantibody, antibodystructure, structureconfirmation, confirmationnsmol, nsmolquantitation, quantitationbrentuximab, brentuximabcetuximab, cetuximabrituximab, rituximabdrugs, drugsmrm, mrmnsmoltm, nsmoltmvedotin, vedotinanalysis, analysisplasma
Shimadzu Solutions for Biopharmaceutical - Application Notebook
2018|Shimadzu|Příručky
C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…
Klíčová slova
acid, acidamino, aminoantibody, antibodyglycan, glycannsmol, nsmolerexim, ereximstructure, structurenews, newsaggregates, aggregatesanalysis, analysismrm, mrmnucleic, nucleicglycans, glycanssizer, sizeraggregate
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…
Klíčová slova
antibody, antibodybevacizumab, bevacizumabconfirmation, confirmationstructure, structurequantitation, quantitationnsmol, nsmolhuman, humanmrm, mrmaccuracy, accuracyftfsldtsk, ftfsldtsknsmoltm, nsmoltmdrugs, drugsplasma, plasmaproteolysis, proteolysischromatograms
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis
2017|Shimadzu|Aplikace
LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…
Klíčová slova
antibody, antibodybevacizumab, bevacizumabconfirmation, confirmationstructure, structurequantitation, quantitationnsmol, nsmolhuman, humanaccuracy, accuracymrm, mrmnsmoltm, nsmoltmftfsldtsk, ftfsldtskplasma, plasmaproteolysis, proteolysisdrug, drugaverage
